Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Diabetes Health Reference Charts
Type 1 Issues Archives
Print | Email | Share | Comments (0)

Is Levemir the Better Basal Insulin? Researchers Think So


Apr 1, 2006

From the Spring Research Guide

Compared with other basal insulins, French researchers suggest that insulin detemir (Levemir) may offer a “better reproducibility.” In addition, it may also reduce the risk of hypoglycemia and lead patients to titrate their insulin doses more easily.

Levemir is the latest basal insulin to receive FDA approval. In previous studies, the researchers say that Levemir was associated with “significantly less within-subjects variability for the pharmacodynamic endpoints than both NPH insulin and [Lantus].” They add, “Day-to-day within-subject variations in plasma glucose were significantly lower with insulin detemir than with human NPH insulin.”

Similar results have been reported in patients with type 2.

“Nightly eight-hour plasma glucose recordings showed a smoother and more stable profile with insulin detemir than with NPH insulin,” say the researchers. “In patients with type 1 diabetes, the combination of insulin detemir with mealtime [NovoLog] provides a smoother and more stable profile with lower postprandial plasma glucose levels than the combination of NPH insulin with regular human insulin before each meal.”

The risk of hypoglycemia was also significantly lower with Levemir than with NPH insulin.

Diabetes and Metabolism, September 2005


Categories: Diabetes, Diabetes, Insulin, Lantus, Low Blood Sugar, Professional Issues, Type 1 Issues, Type 2 Issues



You May Also Be Interested In...


Click Here To View Or Post Comments

Apr 1, 2006

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.